Transcu's current focus includes transdermal drug delivery systems and specialised cosmetic products for the pharmaceutical and cosmeceutical industries. Its transdermal drug delivery technologies allow the local and systemic delivery of drugs through the skin into the body. This innovative, pain-free, non-invasive method can be customised for a wide variety of medical, pharmaceutical and cosmeceutical applications, as an alternative to injections, oral pills, and other drug delivery methods such as transmucosal and inhalation.
Transcu's cosmetics business consists of two skincare lines, Electore (for women) and guiliano Fujiwara Electore (for men). Using mineral ore as their key ingredient, the products contain abundant natural minerals and ions which promote skin rejuvenation.
Transcu has recently incorporated Transcu Green Tech Pte. Ltd (“Green Tech”) to invest, research, manufacture, market as well as manage the intellectual property of alternate and renewable energy related technologies. Green Tech has ventured into Biomass to Liquid gasification technology which has a broad range of applications in large potential markets, covering the entire value chain of biomass businesses.
As a knowledge-based company, Transcu holds patents for at least three device inventions and has over 500 live filings for patents applications and formulations worldwide. Transcu has already succeeded in generating revenues from licensing its proprietary technologies to strategic business partners and anticipates sustainable revenues from manufacturing, distribution and sale of end-products using its proprietary technologies.
Our mission is to develop and nurture technologies that will significantly enhance the quality of human life. Transcu aspires to achieve this through cutting-edge research and development, efficient manufacturing processes, effective sales and marketing and mutually productive collaborations with strategic business and industry partners.